SCHACHLE JOSEPH K 4
4 · Opus Genetics, Inc. · Filed Apr 27, 2026
Research Summary
AI-generated summary of this filing
Opus Genetics (IRD) COO Joseph Schachle Sells Shares
What Happened Joseph K. Schachle, Chief Operating Officer of Opus Genetics (IRD), disposed of 4,697 shares on April 23, 2026. The shares were sold at $5.22 per share for a total transaction value of $24,519. This sale was executed automatically to satisfy tax withholding obligations arising from a restricted stock unit (RSU) vesting and settlement event, not as a discretionary open-market trade by the insider.
Key Details
- Transaction date: 2026-04-23; Sale price: $5.22 per share; Shares sold: 4,697; Total value: $24,519.
- Transaction code: S (sale); footnote indicates tax withholding (automatic sale to cover taxes from RSU vesting).
- Shares owned after transaction: not specified in the provided filing.
- Filing date: 2026-04-27 — filed on the Form 4 within the reporting deadline (timely).
Context This was a routine, non-discretionary sale to satisfy tax withholding on vested RSUs (footnote F1). Such tax-withholding disposals are common and do not necessarily indicate the insider’s market view. For retail investors, purchases are generally more informative about insider sentiment; this filing documents a required administrative sale rather than a voluntary cash-raising trade.
Insider Transaction Report
- Sale
Common Stock
[F1]2026-04-23$5.22/sh−4,697$24,519→ 296,084 total
Footnotes (1)
- [F1]The shares reported on this line were sold automatically on behalf of the Reporting Person, as required by the Company to satisfy tax withholding obligations that arose in connection with a vesting and settlement event from a restricted stock units award. This transaction does not represent a discretionary trade by the Reporting Person.